Association [menp]
Oral [spco]
Endothelin Receptor Antagonists [moft]
Risks [qlco]
cardiovascular events [fndg]
Mortality [qnco]
Meta-Analysis [inpr]
randomized [resa]
Controlled [ftcn]
Trial [resa]
Endothelin Receptor Antagonists [moft]
Variety [cnce]
Disorders [dsyn]
Including [ftcn]
Pulmonary artery hypertension [patf]
Sclerosis, Systemic [dsyn]
diabetic [fndg]
Kidney Diseases [dsyn]
Several [qnco]
Tumors [neop]
Reported [inpr]
adverse events [fndg]
Increased [qnco]
Cardiovascular morbidity [dsyn]
Mortality [qnco]
Cast [medd]
doubt [menp]
Application [hlca]
Conduct [inbe]
Meta-Analysis [inpr]
Endothelin Receptor Antagonists [moft]
Increased [qnco]
Cardiovascular disease [dsyn]
Mortality [qnco]
Searched [acty]
PubMed [inpr]
GOV [gngm]
Controlled Clinical Trial [inpr]
Database [inpr]
randomized controlled trials [inpr, resa]
Published [ocac]
Inclusion Criteria [qlco]
included [ftcn]
Study duration [tmco]
3 Weeks [tmco]
randomized [resa]
Control Group [grup]
Receive [qlco]
Oral [spco]
placebo [topp]
Availability [ftcn]
cardiovascular events [fndg]
Trial [resa]
Meet [idcn]
Inclusion Criteria [qlco]
Cases [ftcn]
Group [idcn]
Cases [ftcn]
placebo [topp]
Group [idcn]
Compared [acty]
Control Group [grup]
Risk Ratio [qnco]
Group [idcn]
P NOS [aapp, imft]
summary [inpr]
Risk Ratio [qnco]
cardiovascular events [fndg]
Group [idcn]
P NOS [aapp, imft]
Pooled [cnce]
Endothelin Receptor Antagonists [moft]
treatment [ftcn]
???lead [elii, hops]
Edema [patf]
Anaemia [dsyn]
Abnormal [qlco]
Transaminase [aapp, enzy]
Levels [qlco]
Increased [qnco]
Proportion [qnco]
Discontinued [fndg]
therapy [ftcn]
treatment [ftcn]
side effects [ftcn]
Risk Ratio [qnco]
P NOS [aapp, imft]
Episodes [tmco]
Headache [sosy]
Dyspnea [sosy]
Active [ftcn]
therapy [ftcn]
Control Groups [grup]
Endothelin Receptor Antagonists [moft]
therapy [ftcn]
Increased [qnco]
cardiovascular events [fndg]
Edema [patf]
Fluid retention NOS [patf]
Anaemia [dsyn]
Liver Disorder [dsyn]
Enzymes [enzy, orch]
Large [qnco]
Clinical Studies [resa]
randomized [resa]
Controlled [ftcn]
Needed [qlco]
Safety [hcpp]
Application [hlca]
Endothelin Receptor Antagonists [moft]
